Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment.
Pataia, Vanessa Papacleovoulou, Georgia Nikolova, Vanya Samuelsson, Anne-Maj Chambers, Stephanie Jansen, Eugene Taylor, Paul D Poston, Lucilla Williamson, Catherine
Pataia, Vanessa
Papacleovoulou, Georgia
Nikolova, Vanya
Samuelsson, Anne-Maj
Chambers, Stephanie
Jansen, Eugene
Taylor, Paul D
Poston, Lucilla
Williamson, Catherine
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
en
Date of publication
2018-05-24
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Paternal cholestasis exacerbates obesity-associated hypertension in male offspring but is prevented by paternal ursodeoxycholic acid treatment.
Translated Title
Published in
Int J Obesity 2-19; 43(2):319-30
Abstract
Obesity is a heterogeneous phenotype and risk associations to non-communicable diseases such as cardiovascular disease and type 2 diabetes are influenced by several factors. The paternal metabolic status at the time of conception influences offspring susceptibility to developing obesity and adiposity-associated cardiometabolic disease. Cholestatic liver diseases are characterized by raised circulating serum bile acid levels and dyslipidemia, and are commonly treated with ursodeoxycholic acid (UDCA). We hypothesized that paternal cholestasis alters offspring susceptibility to developing obesity and adiposity-associated cardiometabolic disease and that this may be modified by paternal UDCA treatment.